Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production
July 22nd, 2022
News
All Categories
ACDL
APDN in the News
CertainT®
Coronavirus
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
mpox
PGx
Press Release
Uncategorized
Vaccines
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
DNA traceability, isotopic testing as evidence under UFLPA
June 23rd, 2022
U.S. Gov’t Guidance Permits DNA Traceability, Isotopic Testing as Evidence
June 21st, 2022
How to Protect Your Brand with a Cotton Traceability Ecosystem
June 9th, 2022
Positive Preclinical Data for LinearDNA™ as Novel Cancer Vaccine Strategy
June 7th, 2022
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 12th, 2022
APDN Schedules FY’22 Q2 Results Conference Call & Webcast
May 9th, 2022
APDN Awarded NYC-based ‘Return-to-Office’ Health Services Contract
April 6th, 2022